Multiple Myeloma and Local Radiation Therapy

“The ability of Resveritrol (RSV) to modify the effect of radiation exposure in normal and cancer cells has indeed been shown quite convincingly…”

Multiple myeloma (MM) patients can undergo radiation for many reasons. During my four years of conventional therapies from ’94-’97 I underwent local radiation twice.  I consider local radiation therapy to be the most useful conventional therapy for multiple myeloma. Yes, I live with serious long-term side effects from my radiation therapy but radiation bought me time to find an alternative therapy that put me into complete remission.

To be more specific, a myeloma patient might have a lesion in a bone or in his/her spine that can be causing pain and/or damage. Radiation can zap the lesion relieving the immediate concern.

The two challenges that all multiple myeloma patients face is that

  1. radiation therapy is a temporary fix and
  2. radiation therapy causes collateral damage aka side effects

In my case local radiation caused a side effect called radiation-induced limbo-sacral plexopathy (RILP). This is a fancy medical term for nerve damage. Radiation causes internal scarring. The scarring interferes with nerve function.

If you are a myeloma patient considering radiation therapy for any reason please read the studies linked and excerpted below.

Please watch the webinar linked on the right of the page to learn about both conventional and non-conventional multiple myeloma therapies.

Thank you,

David Emerson

  • MM Survivor
  • MM Cancer Coach
  • Director PeopleBeatingCancer

Synergistic effect of resveratrol and radiotherapy in control of cancers.

“The ability of Resveritrol (RSV) to modify the effect of radiation exposure in normal and cancer cells has indeed been shown quite convincingly, the combination of RSV and radiation (IR) exhibiting synergistic effects on different cancer cells. This is relevant since controlled exposure to IR is one of the most frequently applied treatments in cancer patients…

Hyperbaric oxygen therapy in the treatment of radio-induced lesions in normal tissues: a literature review

“Late complications are one of the major factors limiting radiotherapy treatment, and their treatment is not codified. Hyperbaric oxygen (HBO) has been used in combination with radiotherapy for over half a century, either to maximise its effectiveness or in an attempt to treat late complications…”

 

Posted in Multiple Myeloma, non-conventional therapies Tagged with:

Atypical Mole Syndrome and Dysplastic Nevi- Melanoma Risk

“Atypical Mole Syndrome is the most important phenotypic risk factor for developing cutaneous melanoma…”

If you have AMS and if your family is affected by AMS then, according to the study linked and excerpted below, your risk of mel. increases dramatically.

While the proposed solution to this increased risk, at least as far as the article is concerned, is to monitor your skin regularly.

My belief as a long-term cancer survivor and cancer coach is to also practice evidence-based, non-toxic therapies shown to both reduce your risk of mel. as well as reduce your risk of skin damage.

An external file that holds a picture, illustration, etc. Object name is cln-66-03-493-g002.jpg

Prospective studies show that the risk of melanoma in members of families affected by AMS and FAMMM is significant, with an estimated cumulative risk of 49% in individuals 10 to 50 years of age and 82% in individuals 72 years of age.32

Have you been diagnosed with AMS? Do you have dysplastic nevi? Scroll down the page, post a question or comment and I will reply ASAP.

Thanks,

David Emerson

Cancer Survivor

Cancer Coach

Director PeopleBeatingCancer

Atypical mole syndrome and dysplastic nevi: identification of populations at risk for developing melanoma – review article

“Atypical Mole Syndrome is the most important phenotypic risk factor for developing cutaneous melanoma, a malignancy that accounts for about 80% of deaths from skin cancer. Because the diagnosis of melanoma at an early stage is of great prognostic relevance, the identification of Atypical Mole Syndrome carriers is essential, as well as the creation of recommended preventative measures that must be taken by these patients...”

Although it corresponds to only 4% of all skin cancers, it accounts for 80% of skin cancer deaths.4 Because early detection of the disease is implicit in its cure and only 14% of patients with metastatic disease survive beyond 5 years,46knowledge of factors that increase an individual’s risk for developing melanoma and diagnosis at an early stage of the disease have great prognostic relevance

Clinical Diagnosis

An external file that holds a picture, illustration, etc. Object name is cln-66-03-493-g001.jpg

Clinically, a dysplastic nevus is most often a spotted lesion of 5 mm or more in diameter, with irregular and poorly defined borders and variable shades of brown, and it may present a reddish hue, with bleaching accomplished using vitropressure.18 It often presents a central papule, surrounded by a pigmented macular ring, giving the appearance of a “fried egg”.18 Thus, there is considerable overlap with the ABCDE rule used for clinical diagnosis of melanoma, namely, A: asymmetry, B: irregular borders C: varied colors, D: diameter > 6 mm and E: elevation (simultaneous presentation of macular and papular components) (Figure 1).3,12,18

CONCLUSION

AMS demonstrably increases the risk of developing melanoma, a malignant neoplasm for which incidence have increased significantly in recent decades and for which early diagnosis is of great importance in the prognosis of the disease.4,5

 

Posted in Skin Cancer Tagged with:

Integrative Therapy for Multiple Myeloma

TQ can enhance the anticancer activity of bortezomib in vitro and in vivo and may have a substantial potential in the treatment of Multiple Myeloma

Image result for image of chemotherapy toxicity

Newly diagnosed multiple myeloma (MM) patients are told that MM is incurable but very treatable. This means that there are many FDA approved chemotherapy regimens that have shown the ability to kill MM. The 800 lb guerrilla in the room hiding behind your oncologist is the fact that MM is incurable and that every MM who adheres strictly to conventional MM oncology will experience remission, relapse, remission, relapse and end stage MM. While a small percentage of MM patients can experience long remissions of 10-12 years, according to the American Cancer Society, the average five year survival rate is 48%. Less than half of newly diagnosed MMers will live for five years.

Evidence-based integrative therapies such as thymoquinone, discussed below, have been shown to “enhance the anticancer activity of bortezomib” while overcoming chemoresistance to velcade (bortezomib).

I am a long-term MM survivor and MM cancer coach. Please watch the free webinar linked on the right side of the page to learn about the MM cancer coaching program. Let me know if you have any questions.

Thank you,

David Emerson

  • MM Survivor
  • MM Cancer Coach
  • Director PeopleBeatingCancer

Thymoquinone

Thymoquinone is a phytochemical compound found in the plant Nigella sativa. It is also found in select cultivated Monarda fistulosa plants grown and steam distilled in the USA producing an essential oil…”

Thymoquinone overcomes chemoresistance and enhances the anticancer effects of bortezomib through abrogation of NF-κB regulated gene products in multiple myeloma xenograft mouse model.

“With the advent of novel targeted agents, the median survival rate has increased to 5 -7 years. However, majority of patients with myeloma suffer relapse or develop chemoresistance to existing therapeutic agents.

Thus, there is a need to develop novel alternative therapies for the treatment of MM…

Our results show that TQ inhibited the proliferation of MM cells irrespective of their sensitivity to doxorubicin, melphalan or bortezomib

Overall, our results demonstrate that TQ can enhance the anticancer activity of bortezomib in vitro and in vivo and may have a substantial potential in the treatment of MM.”

 

Posted in integrative therapy, non-conventional therapies Tagged with:

Pancreatic Cancer Patients Benefit from Prehabilitation

“… patients with newly diagnosed, potentially curable pancreatic cancer can indeed adhere to a regimen of preoperative exercise, or prehabilitation.
”

Image result for image of pancreatic cancer surgery

I think the most low-tech therapies can benefit cancer patients the most. The articles linked and excerpted below state that prehabilitating before chemo, radiation or surgery can result in pancreatic cancer patients doing better.

My mom recently fell and broke her hip. She’s fine. But the key to remaining living independently will be her ability to rehabilitate. Obviously mom didn’t know that she was going to fall and break a hip. But if she had known, she would have “pre-habilitated.” She would have prepared for her surgery and coming physical rehab.

If you have been recently diagnosed with pancreatic cancer whether you have surgery, chemo or radiation you can prepare or pre-babilitate.

I am a long-term survivor of a different but equally complicated cancer. I rely on evidence-based, non-conventional therapies to keep me in complete remission.

Have you been diagnosed with pancreatic cancer? Are you eligible for Whipple surgery? Are you considering undergoing chemo? Scroll down the page, post a question or comment and I will reply ASAP.

Thank you,

David Emerson

  • Cancer Survivor
  • Cancer Coach
  • Director PeopleBeatingCancer

Preoperative Exercise Program for Pancreatic Cancer Patients

“Preoperative chemotherapy and chemoradiation can benefit patients with localized pancreatic cancer, but such regimens may exacerbate an already high symptom burden and diminish patients’ functional status…

“Patients with pancreatic cancer can rapidly get debilitated, even when their tumor burden is small,”…“Unlike patients with colon or breast cancer—who can have widespread metastatic disease and still be completely functional—patients with pancreatic cancer can have a 1-cm tumor and be cachectic and profoundly ill…”

Dr. Katz and colleagues are investigating an individualized exercise program for pancreatic cancer patients undergoing preoperative chemotherapy. The researchers have already demonstrated that despite the high symptom burden, patients with newly diagnosed, potentially curable pancreatic cancer can indeed adhere to a regimen of preoperative exercise, or prehabilitation.
 In addition, the researchers’ preclinical data indicate that the exercise program could increase chemotherapy efficacy…

10 Ways to Prepare for Surgery

  1. Be your best.
  2. Familiarize yourself with the surgery.
  3. Speak up.
  4. Learn about anesthesia.
  5. Ask about your diet.
  6. Know what to expect after surgery.
  7. Practice relaxation techniques.
  8. Plan for medications.
  9. Prepare your home.
  10. Pack a bag.
“BACKGROUND: Probiotics are live microorganisms, which as drugs or food supplements help to maintain health beneficial microbial balance in the digestive tract of a human or other host. Probiotics by their properties may help strengthen homeostasis and thus reduce side effects associated with cancer treatment. Experimental evidence suggests that probiotics might have beneficial effect on the toxicity of anticancer therapy…
 
Despite limited data, it seems that probiotic bacteria as live microorganisms could be safely administered even in the setting of neutropenia…

 

Posted in non-conventional therapies Tagged with:

Cannavaping for Cancer, What Do We Know So Far?

A trend called “cannavaping” – the vaping of cannabis products, is being looked at as a possible treatment for cancer patients.

There are a lot of opinions out there relating to cannabis and cancer. More scientific research is needed, though most people will agree that cannabis helps with pain, nausea, and other side effects of cancer and cancer treatments. Some even say that cannabis, particularly the compound cannabidiol (CBD), one of the major phytocannabinoids in the plant, might even shrink tumors and help prevent cancer from spreading.

Image result for image of Cannavaping

A trend called “cannavaping” – the vaping of cannabis products, is being looked at as a possible treatment for cancer patients. Researchers at the University of Lausanne whipped up their own cannabis-laden oils for use in e-cigarettes. They discovered that this may be a more reliable delivery method of the medicine than pills containing the extracts. Using e-pens and vaporizers, patients could get regularly timed microdoses throughout the day, providing them with better relief.

Related imageCBD, when used as a treatment or medicine, has been proven to help control and relieve pain. It is also a wonderful treatment for the nausea that can accompany many cancer treatments. Some research has even indicated that CBD may help to shrink tumors or to stop cancer tumors from spreading and invading other body systems.

This treatment actually has been backed up by scientific research. In 2009, a research team at Complutense University in Spain found that THC induced the death of brain cancer cells through autophagy. Similar effects were discovered during a study co-led by Complutense University and the University of Anglia in the UAE. Scientists there induced mice with human breast cancer cells and found that when treated with doses of THC, there was an anti-tumor response. However, researchers do not know which cannabinoid receptors are responsible for the response to THC.

While scientific tests in laboratory settings – test tubes and mice – have shown positive results for shrinking cancer tumors and stopping the spread of cancer, one must also consider that no human trials have been conducted. Because marijuana is still a schedule I drug in the United States, it is difficult to test it for medical uses. Also, it is unlikely that human trials will ever commence. This is because trials are usually run compared to a placebo. It would be unethical to give dangerously ill people – such as those with cancer – a placebo.

However, experts warn against self-medicating with cannabis or discontinuing traditional, doctor recommended therapies.

Why Vaporizing Helps Better than Smoking?

When it comes to vaporizing cannabis – there’s little doubt that vaporization is the healthier alternative to smoking. Smoking and vaporizing help to get the active cannabinoids CBD and THC into a patient’s bloodstream faster than edibles or pill forms of both the compounds. Vaporizing also allows for more of the active compound to be delivered to the patient – smoking carbonizes much of the active phytocannabinoids that are helpful in the treatment of cancer and cancer symptoms, along with the side effects of cancer treatments.

Can you Overdose on Marijuana?

Overdosing on marijuana is a concern among those considering it as a potential therapy for the side effects of cancer treatments and the symptoms of cancer itself as well as the symptoms of other illnesses. However, there have been no known deaths related to the overdose of marijuana ever reported.

Scientists measure a drug’s safety by something called the therapeutic index. This is simply the measure of a drug’s therapeutic dose against its lethal dose. Marijuana’s therapeutic index is approximately 40,000 to 1. In other words, you would have to take 40,000 times the therapeutic dose in order to overdose on marijuana so that it kills you.

However, this does not mean that you cannot take too much. Ingesting too much marijuana can lead to side effects like paranoia and agitation. While such side effects do tend to wear off within 24 hours, it is never a good idea to take too much of any drug.

While the doctor is still out, so to speak, on the therapeutic benefits of cannabis and vaping marijuana, it has shown promise as a treatment not only for cancers, but for a large number of other diseases. From seizures to psychological illnesses like anxiety, depression, and even PTSD, cannabis is proving to be a very important drug to consider in the treatment – and the research – of treating and helping to prevent illness and disease.

Author

michael.jpg

Michael is a marketing and creative content specialist at GotVape.com with primary focus on customer satisfaction. Technology and fitness combined healthy lifestyle obsession are his main talking points.

Posted in non-conventional therapies

The Melanoma Paradox-

While the number of skin cancer cases—specifically for melanoma—is anticipated to increase by 14 percent this year, the number of deaths from melanoma is decreasing by 4 percent.1

There is no paradox here. Analysis without bias is what is required. Sherlock Holmes (Sir Arthur Conan Doyle) said “Once you eliminate the impossible, whatever remains, no matter how improbable, must be the truth.” Applying this philosophy to the melanoma paradox,

  • Melanoma diagnoses will increase by 14% in 2017
  • Melanoma deaths will decrease by 4% in 2017
  • Melanoma is incurable with an average five-year survival rate of less than 10%– current standard-of-care therapies don’t help much-
Picture of Malignant Melanoma

Based on the assumptions above I believe that melanoma is over diagnosed. This over diagnosis may be a matter of “better safe than sorry” for the patient. While over diagnosis will cost insurers and patients more money, over diagnoses may save lives in the long run.

The real issue is possible over-treatment. Undergoing chemo for a diagnosis of melanoma can be rough on the patient. Especially if the patient doesn’t have cancer.

It is important to understand that there are evidence-based, non-toxic therapies that studies have shown will reduce the risk of melanoma becoming metastatic.

I am a cancer survivor of a different but incurable cancer. I have learned that cancer patients must look beyond conventional oncology when it comes to managing their own incurable cancers.

Have you been diagnosed with melanoma? What stage? Please scroll down the page, post a question or comment and I will reply to you ASAP.

Thank you,

David Emerson

  • Cancer Survivor
  • Cancer Coach
  • Director PeopleBeatingCancer

THE SKIN CANCER PARADOX

“Recent statistics from the American Cancer Society revealed a paradox about skin cancer: While the number of skin cancer cases—specifically for melanoma—is anticipated to increase by 14 percent this year, the number of deaths is decreasing by 4 percent.1,2 How can it be that while new cases are on the rise, so is the number of survivors?

We asked skin cancer experts Ivor Caro, M.D. and Josina Reddy, M.D., Ph.D., to help make sense of this puzzling statistic and point to ways that may help reduce skin cancer rates…

In instances where surgery alone can’t treat skin cancer, medicines targeting specific gene mutations that cause skin cancers are now available to patients, as well as treatments that stimulate the immune system to recognize skin cancers and mount an attack on them.9 These types of therapies used to treat advanced forms of skin cancer may slow the growth of the cancer or make it shrink...1,6″

 

 

Posted in non-conventional therapies Tagged with:

Stage II-IIIA Non Small Cell Lung Cancer? Buy Time with Mix of Therapies

“The targeted therapy gefitinib appears more effective in preventing recurrence after lung cancer surgery than the standard of care, chemotherapy”

A lung cancer diagnosis of stage 2 or 3 is not about one procedure to cure or not cure the patient. My experience as a long-term survivor of an incurable cancer is that each patient must combine the most effective therapies of both conventional (FDA approved) and evidence-based non-conventional therapies to most effectively treat their cancer for the long-term.

Make no mistake. Lung cancer is an aggressive cancer. If you are staged at 2 or 3 then “the five-year survival for patients with stage II-IIIA NSCLC is only 40 percent.. ” The study linked and excerpted below talks about a conventional therapy that can buy you time to undergo evidence-based, non-conventional therapies. Which in turn may buy you more time…

Treating Lung Cancer With Surgery

Surgery to remove as much of the lung cancer as possible is the first step in managing your cancer. However, chances are, your cancer will relapse. Many cancers do. My point is to anticipate this relapse and take the steps necessary to work with this possibility.

I have been “buying more time” from my “incurable cancer” since 1999.  When my oncologist told me that there was nothing more that she could do for me in September of 1997, I decided to undergo a controversial non-conventional cancer therapy. I reached complete remission by early 1999.

Survivors of my cancer, multiple myeloma, always relapse. Therefore I consider the evidence-based, non-toxic therapies I do each day to be buying time until I relapse. One day at a time…

Have you been diagnosed with lung cancer? What stage? What therapies have you undergone? Please scroll down the page, post a question or comment and I will reply to you ASAP.

Thank you,

David Emerson

  • Cancer Survivor
  • Cancer Coach
  • Director PeopleBeatingCancer

targeted therapy can delay recurrence of intermediate-stage lung cancer

“The targeted therapy gefitinib appears more effective in preventing recurrence after lung cancer surgery than the standard of care, chemotherapy…

In a phase III clinical trial, patients with epidermal growth factor receptor (EGFR)-positive, stage II-IIIA non-small cell lung cancer (NSCLC) who received gefitinib (Irressa) went about 10 months longer without recurrence than patients who received chemotherapy…

Due to high chance of recurrence, the five-year survival for patients with stage II-IIIA NSCLC is only 40 percent. About 25 percent of all patients who are diagnosed with NSCLC are eligible to have surgery to remove the tumors with the hope of a cure. Among that group, about 30 percent or 140,000 people worldwide have an EGFR mutation in the tumor and may benefit from adjuvant treatment with EGFR-targeted therapy to reduce the chance of recurrence

 

Posted in non-conventional therapies Tagged with:

Chemotherapy-Induced Peripheral Neuropathy (CIPN) Therapy

While some agreement has emerged on the best wavelengths of light… there is no agreement on whether continuous wave or pulsed light is best for CIPN…

I am a long-term survivor from an incurable blood cancer called multiple myeloma. I live with many side effects from toxic chemotherapy and radiation. I am thankful that I have numbness in my lower body but I do not suffer from the burning and pins/needles that  CIPN or chemotherapy-induced peripheral neuropathy, survivors talk about.

According to studies, 30%-40% of cancer patients develop CIPN. The pain, tingling and numbness of this nerve damage often does not heal but in fact worsens over time.

Related image

While the study linked below is conservative in it’s promotion of laser therapy for CIPN, I will say that cancer patients who live with this nerve pain suffer endlessly and should not wait for conventional medicine to bless laser therapy before they act. Don’t wait for FDA approval…

Unfortunately, the second article linked below reads like a paid commercial for laser therapy. So I have to add caution to the reader. You’ve heard of the term “snake oil?” Well, unfounded medical claims is the reason why the FDA was founded in the first place.

I have learned that the sooner

Thanks,

David Emerson

Cancer Survivor

Cancer Coach

Director PeopleBeatingCancer

Effect of Pulsing in Low-Level Light Therapy

“Background and Objective- Low level light (or laser) therapy (LLLT) is a rapidly growing modality used in physical therapy, chiropractic, sports medicine and increasingly in mainstream medicine. LLLT is used to increase wound healing and tissue regeneration, to relieve pain and inflammation, to prevent tissue death, to mitigate degeneration in many neurological indications. While some agreement has emerged on the best wavelengths of light and a range of acceptable dosages to be used (irradiance and fluence), there is no agreement on whether continuous wave or pulsed light is best and on what factors govern the pulse parameters to be chosen…

Conclusion-There is some evidence that pulsed light does have effects that are different from those of continuous wave light. However further work is needed to define these effects for different disease conditions and pulse structures…”

The Treatment that Can Free You From Debilitating Nerve Pain

““The pain was so bad, I didn’t think I could take it anymore. I was at my wit’s end!” So said Cheryl Greenawalt of the excruciating foot and lower-leg neuropathy she’d been battling for nearly a decade and a half. The burning. The numbness. The “pins and needles” sensation…

These days, she maintains her miraculous results with a periodic one-hour treatment every few months…”

 

Posted in side effects ID and prevention Tagged with:

Relapsed/Refractory Multiple Myeloma Therapy W/ Side Effects

Patients with double-refractory multiple myeloma had an overall response rate of 68% and patients with high-risk disease had a response rate of 56%

If you’ve been told that your MM is “double refractory” then you probably will be ecstatic at the news that you have additional therapies that can put you into remission again. However please understand that this new chemo cocktail comes with serious side effects.

Image result for image of chemotherapy toxicity

I am pointing this out to you not to be annoying but because I believe that side effects from toxic therapies can be managed. Integrative therapies are evidence-based and have shown to reduce the damage done to healthy cells.

Forty-two percent of patients experienced a grade 3/4  adverse event including

  • hematologic toxicities (40%),
  • hyperglycemia (25%), and
  • pneumonia (15%).

Immune-related events included

  • pneumonitis (13%) and
  • hypothyroidism (10%).

Most immune-related events were grade 1/2 and resolved with interruption of therapy

I am a long-term MM survivor and MM cancer coach. Please watch the free webinar linked on the right of the page and learn about evidence-based integrative therapies. Scroll down the page to ask me a question or make a comment. I will reply to you ASAP.

Thank you,

David Emerson

  • MM Survivor
  • MM Cancer Coach
  • Director PeopleBeatingCancer

Pembrolizumab Combo Active in Relapsed/Refractory Myeloma

“Combination treatment with pembrolizumab, pomalidomide, and low-dose dexamethasone resulted in durable responses in patients with relapsed or refractory multiple myeloma…

The study included 48 patients with relapsed/refractory disease. The median number of prior lines of therapy was three and patients had received both immunomodulatory agents and proteasome inhibitors

Almost two-thirds (60%) of patients experienced an objective response to treatment. Four patients (8%) had a stringent complete response or complete response, nine patients (19%) had a very good partial response, and 16 patients (33%) had a partial response…

Patients with double-refractory disease had an overall response rate of 68% and patients with high-risk disease had a response rate of 56%

“Understanding the limitation of comparing different studies, the clinical data from the current study support a synergistic activity between pomalidomide and pembrolizumab that led to high overall response rate (60%) that were remarkably durable,” the researchers wrote. “The lack of single-agent activity for the PD-1 inhibitor nivolumab in multiple myeloma patients suggests that myeloma is refractory to anti–PD-1 therapy.”

Forty-two percent of patients experienced a grade 3/4  adverse event including hematologic toxicities (40%), hyperglycemia (25%), and pneumonia (15%). Immune-related events included pneumonitis (13%) and hypothyroidism (10%). Most immune-related events were grade 1/2 and resolved with interruption of therapy

 

 

Posted in Multiple Myeloma Tagged with:

Multiple Myeloma Treatment Options- Evidence-based Conventional and Non-Conventional

Multiple Myeloma Patients Must Combine the Best of both Conventional and Non-Conventional Therapies to Manage their Incurable Cancer

If you google “treatment options for multiple myeloma” you will come upon lists and lists of conventional/FDA approved conventional treatments. These therapies are what is called the standard-of-care for MM. That means that your health insurance will probably pay for the therapy as it has been approved by the FDA. The second list below comes from the MMRF website.

Image result for image of multiple myelomaThe newly diagnosed myeloma patient must understand that conventional oncology can’t cure MM. According to the American Cancer Society the five-year survival rate for myeloma patients is 48%. More than half of newly diagnosed myeloma patients will not live five years.

That’s the bad news. The good news is that there is a long and growing list of evidence-based non-conventional myeloma therapies. Specific foods and supplements that research has shown can starve MM.  Lifestyle therapies that have also been shown to fight MM.

Image result for image of curcumin

I am both a long-term MM survivor and MM cancer coach. I have lived in complete remission from my MM since early 1999 by living an evidence-based, non-toxic, anti-MM lifestyle through nutrition, supplementation, bone health, mind-body therapies and more.

Have you been diagnosed with MM? What stage? Are you experiencing any symptoms such as bone pain, anemia or kidney damage?

Please look to the right of this page to register and watch the free webinar about the MM Cancer Coaching Program. Let me know if you have any questions.

thank you,

David Emerson

  • MM Survivor
  • MM Cancer Coach
  • Director PeopleBeatingCancer

The treatment for multiple myeloma may include:

  • Chemotherapy and other drugs.
  • Bisphosphonates.
  • Radiation.
  • Surgery.
  • Stem cell transplant.
  • Plasmapheresis.

Learn more about multiple myeloma treatment options

Multiple myeloma drug therapies
Stem cell transplants
Biphosphonates
Radiation therapy
Surgery
Alternative therapies
Myeloma treatment by stage
Treatment FAQs

Posted in Multiple Myeloma Tagged with:

You can take control of your Multiple Myeloma.

side-widget-mm-webinar-image